Literature DB >> 2182779

Ticlopidine, a new antithrombotic drug: but is it better than aspirin for longterm use?

C Warlow1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2182779      PMCID: PMC1014125          DOI: 10.1136/jnnp.53.3.185

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  A comparison of risk factors and prognosis for transient ischemic attacks and minor ischemic strokes. The Oxfordshire Community Stroke Project.

Authors:  M S Dennis; J M Bamford; P A Sandercock; C P Warlow
Journal:  Stroke       Date:  1989-11       Impact factor: 7.914

2.  XIIth congress of the International Society on Thrombosis and Haemostasis. Tokyo, Japan, 19-25 August 1989. Abstracts.

Authors: 
Journal:  Thromb Haemost       Date:  1989-08-19       Impact factor: 5.249

3.  The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke.

Authors:  M Gent; J A Blakely; J D Easton; D J Ellis; V C Hachinski; J W Harbison; E Panak; R S Roberts; J Sicurella; A G Turpie
Journal:  Lancet       Date:  1989-06-03       Impact factor: 79.321

4.  A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group.

Authors:  W K Hass; J D Easton; H P Adams; W Pryse-Phillips; B A Molony; S Anderson; B Kamm
Journal:  N Engl J Med       Date:  1989-08-24       Impact factor: 91.245

  4 in total
  6 in total

1.  Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events?

Authors:  G J Hankey; J M Slattery; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

Review 2.  Cost considerations in the pharmacological prevention and treatment of stroke.

Authors:  A V Alexandrov; L T Smurawska; W Bartle; P Oh
Journal:  Pharmacoeconomics       Date:  1997-05       Impact factor: 4.981

Review 3.  Platelet aggregation inhibitors in neurology.

Authors:  A Keyser
Journal:  Pharm World Sci       Date:  1993-12-17

Review 4.  Antiplatelet therapy--Part I.

Authors:  S H Goodnight; B M Coull; J H McAnulty; L M Taylor
Journal:  West J Med       Date:  1993-04

5.  Can the long term outcome of individual patients with transient ischaemic attacks be predicted accurately?

Authors:  G J Hankey; J M Slattery; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-07       Impact factor: 10.154

6.  Ticlopidine hydrochloride use and threatened stroke.

Authors:  J F Rothrock; R G Hart
Journal:  West J Med       Date:  1994-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.